IMedis

AI-powered Quality Assurance Platform for Radiology

Health Tech & Life Sciences
Active
Pre-Seed Rehovot Founded 2018
Total raised
$3.7M
Last: Convertible Debt 2021-10
Stage
Pre-Seed
Founded
2018
Headcount
1,037
HQ
Rehovot
Sector
Health Tech & Life Sciences

About

IMedis is developing a comprehensive quality management system for radiology departments. The AI-driven cloud-based solution aggregates and analyzes data from the PACS and RIS. By addressing failure points throughout the radiology workflow, IMedis aims to reduce risk, improve financial efficacy, and create new business opportunities. Duali-Q, IMedis's first commercially available module, allows management and follow-up of errors of omission in CT scans of the chest and the abdomen. Duali-Q was proven to increase detection rates of life-threatening diseases by 13% in a recent study and is now in use by teaching hospitals in the United States, United Kingdom, and Israel.

Funding history · 3 rounds · $3.7M total

2021-10
Convertible Debt $1.4M
2020-01
Equity crowdfunding $1.3M
2018-04
Pre-Seed $1.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is IMedis's primary focus?
IMedis is developing an AI-driven cloud-based quality management system for radiology departments, aggregating and analyzing data from PACS and RIS to reduce risk, improve financial efficacy, and create new business opportunities.
What is Duali-Q and what is its purpose?
Duali-Q is IMedis's first commercially available module, designed for the management and follow-up of errors of omission in CT scans of the chest and abdomen. It has been shown to increase detection rates of life-threatening diseases by 13% in a recent study.
Where is Duali-Q currently in use?
Duali-Q is currently in use by teaching hospitals in the United States, United Kingdom, and Israel.
When was IMedis founded?
IMedis was founded in January 2018.
What was IMedis's first funding round?
In April 2018, IMedis raised a Pre-Seed round of $1,000,000, with Sanara Ventures as a lead investor.
How much did IMedis raise in its crowdfunding campaign?
In January 2020, IMedis raised $1,300,000 through an Equity crowdfunding campaign via ExitValley.
When did IMedis receive CE approval for its radiology scans in the EU?
IMedis received CE approval for its radiology scans in the EU in January 2021.
What was IMedis's most recent funding round?
IMedis's most recent funding round was a Convertible Debt round of $1,400,000 in October 2021.
How many employees does IMedis have?
IMedis has an employee count in the 500+ range, with an exact count of 1037 employees.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine LearningComputer VisionNatural Language Processing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

deep-learningmachine-visionradiologynatural-language-processingimaginghospitalsartificial-intelligencect-scanhealthcare-providersdigital-healthcaremachine-learningcardiovascularquality-controlpatent-pendingqa